Antibiotic Discovery in the Abyss14 November 2017Combining the innovations of synthetic biology with robotic environmental sampling, a team of University of Bristol researchers are travelling to some of the most ‘extreme’ environments on Earth, including Atlantic depths of 4.5km, to find new leads which could help in the global fight against antimicrobial resistance.
Key discoveries offer significant hope of reversing antibiotic resistance23 October 2017Two recent studies led by the University of Bristol provide significant new hope in the fight against antibiotic resistance. By identifying what makes some bacteria resistant to the most commonly prescribed antibiotics, and how this can be reversed, the findings have demonstrated potentially life-saving consequences and could help reverse the tide of antibiotic resistance.
Final Funding Round Open12 February 2017BristolBridge funding for AMR pump-priming projects - deadline 12 noon 19 April 2017
New research describes how bacteria resists ‘last-resort’ antibiotic6 January 2017An international research team, led by the University of Bristol, has provided the first clues to understand how the mcr-1 gene protects bacteria from colistin – a ‘last resort’ antibiotic used to treat life-threatening bacterial infections that do not respond to other treatment options.
New funding round open28 July 2016BristolBridge funding for AMR pump-priming projects, knowledge exchange and impact projects compliant with Official Development Assistance - deadline 12 noon, 26 September 2016.
BristolBridge Inaugural Conference20 April 2016BristolBridge held its inaugural conference on 8 April at Engineers' House which brought together researchers of different disciplines from 12 Schools and Departments. The delegates heard results from the first short projects funded by BristolBridge, viewed posters from the teams of the six newly funded projects and enjoyed presentations from clinical, academic and industrial perspectives which explored the engineering and physical science tools and technologies that are already being applied, or show potential, to tackle the global problem of antimicrobial resistance.